Petitions for Inter Partes Review by Reshape Medical LLC

On April 20, 2018, Reshape Medical LLC (“Petitioner”) filed two Petitions to the USPTO’s Patent Trial and Appeal Board (“Board”) for inter partes reviews of claims 1-30 of U.S. Patent No. 9,456,915 (“the ‘915 Patent”) and claims 1-30 of U.S. Patent No. 9,445,930 (“the ‘930 Patent”), respectively.  Both the ‘915 Patent and the ‘930 Patent are owned by Fulfillium, Inc. and are drawn to intragastric devices for treating obesity.  In each of the Petitions, Petitioner alleges that claims 1-30 of each of the patents are obvious under 35 U.S.C. § 103 over various patent documents.  The inter partes reviews remain pending at the Board and are captioned IPR2018-00957 and IPR2018-00958, respectively.

By:  Jacqueline A. DiRamio

View Attachment (PDF)

View Attachment (PDF)